Walleye Capital’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-35,011
Closed -$385 1626
2021
Q1
$385 Hold
35,011
0.02% 679
2020
Q4
$371 Hold
35,011
0.02% 569
2020
Q3
$369K Sell
35,011
-28,900
-45% -$301K 0.04% 458
2020
Q2
$671K Buy
+63,911
New +$642K 0.15% 175

Other funds holding CHAQ.U

Walleye Capital's CHAQ.U Position: Q2 2021 in Review

Walleye Capital sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q2 2021, closing a stake of 35,011 shares — an estimated $385 sold.

Walleye Capital first reported a position in CHAQ.U in Q2 2020 and held it in 4 quarters. The position peaked at $671K in Q2 2020. 8 funds tracked by Wall St. Rank hold CHAQ.U as of Q2 2021.

  • Walleye Capital reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q2 2021 after selling out during the quarter.
  • Walleye Capital sold 35,011 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q2 2021, an estimated $385.
  • Walleye Capital first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 4 quarters.
  • Walleye Capital's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $671K in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.